09/18/2024 3:19 PM | Eli Lilly and Company (Issuer) Montarce Lucas (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/17/2024 4:08 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:11 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:15 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:17 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 4:19 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2024 3:16 PM | Eli Lilly and Company (Issuer) Skovronsky Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/09/2024 6:03 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/28/2024 3:05 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:47 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:21 PM | Eli Lilly and Company (Issuer) Eli Lilly and Company (Issuer) Zakrowski Donald A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 11:54 AM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 3:12 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:14 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:15 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:17 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:18 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 7:51 AM | Eli Lilly and Company (Filed by) Morphic Holding, Inc. (Subject)
| Form SC TO-T/A | |
08/14/2024 11:27 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 3:31 PM | Eli Lilly and Company (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
08/13/2024 3:19 PM | Eli Lilly and Company (Issuer) Hakim Anat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/12/2024 3:51 PM | Eli Lilly and Company (Subject)
| Form FWP | |
08/12/2024 7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
08/08/2024 10:28 AM | Eli Lilly and Company (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 5:07 AM | Eli Lilly and Company (Filed by) Morphic Holding, Inc. (Subject)
| Form SC TO-T/A | |
07/19/2024 3:16 PM | Brooks Gordon J. (Reporting) Eli Lilly and Company (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/19/2024 5:09 AM | Eli Lilly and Company (Filed by) Morphic Holding, Inc. (Subject)
| Form SC TO-T | |
07/16/2024 3:17 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:18 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:20 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:21 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:22 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 12:19 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 7:40 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/09/2024 3:00 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 6:14 AM | Eli Lilly and Company (Filed by) Morphic Holding, Inc. (Subject)
| Form SC TO-C | |
07/02/2024 3:00 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 1:25 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 3:00 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 1:43 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The real reason Elon is fully endorsing Trump (Ad) Elon Musk is one of mankind’s greatest innovators.
But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk.
This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, |
06/18/2024 3:22 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:23 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 1:49 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 1:03 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 1:23 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 6:48 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 3:14 PM | Eli Lilly and Company (Issuer) Rau Diogo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 5:29 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 5:30 PM | Eli Lilly and Company (Subject) Norton Johna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:14 PM | Eli Lilly and Company (Issuer) Norton Johna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 1:32 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 2:13 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024 3:18 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:19 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 2:20 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 11:04 AM | Eli Lilly and Company (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024 6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:11 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:12 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:13 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:14 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 11:59 AM | AS YOU SOW (Filed by) Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024 12:10 PM | Chevedden John (Filed by) Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024 11:20 AM | Eli Lilly and Company (Subject) Trinity Health Corp (Filed by)
| Form PX14A6G | |
03/11/2024 3:24 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 3:26 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:16 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:18 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 10:44 AM | Eli Lilly and Company (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 2:05 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 3:43 PM | Dozier Eric (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:44 PM | Eli Lilly and Company (Issuer) White Anne E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:34 PM | Eli Lilly and Company (Issuer) Hakim Anat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:36 PM | Eli Lilly and Company (Issuer) Skovronsky Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:23 PM | Eli Lilly and Company (Issuer) Rau Diogo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:25 PM | Eli Lilly and Company (Issuer) Jonsson Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 10:56 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 8:26 AM | Eli Lilly and Company (Subject) PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
| Form SC 13G/A | |
02/08/2024 2:34 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 4:08 PM | Eli Lilly and Company (Subject)
| Form FWP | |
02/07/2024 7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
02/06/2024 6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 3:32 PM | Eli Lilly and Company (Issuer) Hakim Anat (Reporting) Hakim Anat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:20 PM | Eli Lilly and Company (Issuer) White Anne E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Eli Lilly and Company (Subject)
| Form SC 13G/A | |
01/17/2024 3:15 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:17 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:19 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 2:22 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:05 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The real reason Elon is fully endorsing Trump (Ad) Elon Musk is one of mankind’s greatest innovators.
But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk.
This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, |
01/05/2024 1:15 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 2:11 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:40 PM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/18/2023 5:59 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/04/2023 3:17 PM | Eli Lilly and Company (Issuer) Zakrowski Donald A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 6:04 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/21/2023 3:27 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:29 PM | Eli Lilly and Company (Issuer) Runge Marschall S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:15 PM | Baicker Katherine (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |